Scancell founder says the company is ready to commercialise novel medicines to counteract cancer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGLIF.L Regulatory News (GLIF)

  • There is currently no data for GLIF

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Result of placing

25 Jun 2007 18:19

T2 Income Fund Limited25 June 2007 RNS Number:T2 Income Fund Limited25 June 2007 Not for release, publication or distribution in, or into, the United States,Australia, Canada or Japan 25 June 2007 T2 Income Fund Limited RESULT OF PLACING OF NEW ORDINARY SHARES T2 Income Fund Limited (the "Company") announces that, further to theannouncement on 22 June 2007 (the "Announcement"), a total of 5 million newordinary shares in the Company (the "Placing Shares") have been placed byJPMorgan Cazenove at a price of 101.75 pence per Placing Share, raising grossproceeds of approximately £5,087,500 (the "Placing"). The Placing Shares will be issued credited as fully paid and will rank paripassu with the Company's existing ordinary shares, including the right toreceive all dividends and other distributions declared, made or paid on or inrespect of such shares after the date of issue of the Placing Shares.Application has been made for admission of such Shares to trading on the AIMMarket of the London Stock Exchange plc. Grant Thornton Corporate Finance actsas Nominated Adviser to the Company. Dealings in these Placing Shares areexpected to commence on 28 June 2007. Following admission of these PlacingShares there will be 43,000,000 ordinary shares in issue. Jonathan Cohen, chief executive officer of the Investment Manager, and SaulRosenthal, president of the Investment Manager and Non-Independent Director ofthe Company both participated in the placing subscribing for 125,000 PlacingShares each, taking their existing holdings in the Company to 129,000 ordinaryshares (0.3% of the total voting rights of the Company) and 125,000 ordinaryshares (0.3% of the total voting rights of the Company) respectively. Mr Cohenand Mr Rosenthal additionally each hold an interest through an option previouslygranted to the Investment Manager by the Company of 1,194,444 ordinary shares(2.5% of the total voting rights of the Company, on the basis of the issuedshare capital of the Company following exercise of the option). The shareholdings of existing substantial shareholders may change following theissue of the Placing Shares. The Company will issue a notification at a laterdate if it becomes aware of any relevant changes in such shareholdings that arerequired to be notified in accordance with Rule 17 of the AIM Rules. Enquiries: T2 Income Fund Limited:T2 Income Fund Limited:Patrick Conroy, +1 203 983 5282 Grant Thornton Corporate Finance (Nominated Adviser):Philip Secrett / Fiona Kindness, +44 207 383 5100 JPMorgan Cazenove:Angus Gordon Lennox, +44 207 588 2828 Defined terms used in this announcement have, unless the context otherwiserequires, the same meaning given to them in the Announcement. This announcement has been issued by and is the sole responsibility of T2 IncomeFund Limited. JPMorgan Cazenove is acting for the Company and no-one else in relation to thePlacing and will not be responsible to any person other than the Company forproviding the protections afforded to clients or for providing advice inrelation to the Placing or in relation to the contents of this announcement orany other transaction, arrangement or matter referred to herein. This announcement is for information purposes only and does not constitute anoffer to issue or sell, or the solicitation of an offer to acquire or buy, anysecurities to any person in any jurisdiction. In particular, this announcementdoes not constitute an offer to issue or sell, or the solicitation of an offerto acquire, buy or subscribe for, any securities in the United States, Canada,Australia and Japan. The Placing Shares have not been, nor will they be, registered under theSecurities Act or with any securities regulatory authority of any State or otherjurisdiction of the United States, and accordingly may not be offered, sold ortransferred within the United States except pursuant to an exemption from, or ina transaction not subject to, registration under the Securities Act. No publicoffering of the Placing shares will be made in the United States. The PlacingShares are being offered and sold outside the United States to persons who arenot U.S. persons as defined in and in accordance with Regulation S under theSecurities Act ("U.S. Persons"). The Company has not been and will not beregistered under the Investment Company Act and investors will not be entitledto the benefits of such registration. This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
23rd Sep 20147:00 amRNSHalf Yearly Report
19th Sep 20142:55 pmRNSSharedealing
17th Sep 20147:00 amRNSAdditional Listing
16th Sep 20147:00 amRNSEmma Stubbs appointment
5th Sep 20147:00 amRNSNotice of Results
18th Aug 20147:00 amRNSNAV and Trading Update
16th Jul 20147:00 amRNS2014 Second Interim Dividend
20th Jun 20145:25 pmRNSHolding(s) in Company
20th Jun 20147:00 amRNSDirector/PDMR Shareholding
19th Jun 20147:00 amRNSAdditional Listing
12th Jun 20147:00 amRNSDisposal of CLO investments
19th May 20147:00 amRNSAgreement to Dispose of CLO investments
6th May 20147:01 amRNSDirector/PDMR Shareholding
2nd May 20145:00 pmRNSDirector/PDMR Shareholding
30th Apr 20144:56 pmRNSResult of AGM
30th Apr 20147:00 amRNSAGM Statement
24th Apr 20147:00 amRNSDividend Declaration
24th Apr 20147:00 amRNSNet Asset Value(s)
4th Apr 20143:16 pmRNSAnnual Financial Report
26th Mar 20147:00 amRNSFinal Results
24th Mar 20147:00 amRNSNotice of Results
20th Mar 20141:48 pmRNSDirector/PDMR Shareholding
19th Mar 201412:51 pmRNSAdditional Listing
6th Mar 20147:00 amRNS2013 Fourth Interim Dividend - Timetable amendment
26th Feb 201412:11 pmRNSHolding(s) in Company
19th Feb 20141:29 pmRNSHolding(s) in Company
29th Jan 201411:34 amRNSHolding(s) in Company
24th Jan 20144:45 pmRNSDirector/PDMR Shareholding
24th Jan 201412:00 pmRNSDirector/PDMR Shareholding
22nd Jan 201412:10 pmRNSDirector/PDMR Shareholding
22nd Jan 20147:00 amRNSNAV and Trading Update
21st Jan 20147:00 amRNSDividend Declaration
9th Dec 201312:46 pmRNSCancellation of listing from CISX
5th Dec 201311:30 amRNSResult of EGM
5th Dec 20138:00 amRNSDirector/PDMR Shareholding
4th Dec 20133:00 pmRNSSCRIP DIVIDEND - ADDITIONAL LISTING
13th Nov 201311:00 amRNSInvesting policy / Cancellation CISX listing / EGM
6th Nov 201311:00 amRNSHolding(s) in Company
4th Nov 20132:00 pmRNSHolding(s) in Company
29th Oct 20134:30 pmRNSHolding(s) in Company
29th Oct 20134:00 pmRNSChange of Adviser
24th Oct 20137:00 amRNSNAV and Trading Update
21st Oct 201312:45 pmRNSResult of EGM
9th Oct 20137:00 amRNSDividend Declaration
3rd Oct 201311:30 amRNSPublication of circular and General Meeting
1st Oct 20137:00 amRNSResults of Placing
30th Sep 20138:01 amRNSIssue of Equity
30th Sep 20137:00 amRNSInterim Results
24th Sep 20132:00 pmRNSHolding(s) in Company
19th Sep 20133:45 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.